OCRL Antikörper (Internal Region)
-
- Target Alle OCRL Antikörper anzeigen
- OCRL (Oculocerebrorenal Syndrome of Lowe (OCRL))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser OCRL Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Spezifität
- OCRL Polyclonal Antibody detects endogenous levels of OCRL protein.
- Produktmerkmale
- Rabbit Polyclonal to OCRL.
- Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- Synthesized peptide derived from the Internal region of human OCRL.
- Isotyp
- IgG
- Top Product
- Discover our top product OCRL Primärantikörper
-
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 146-239) antibody
OCRL Reaktivität: Human WB, ELISA, IHC (p), RNAi Wirt: Maus Monoclonal 4A6 unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (C-Term) antibodyOCRL Reaktivität: Human WB, IHC (p), ICC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 146-240) antibodyOCRL Reaktivität: Human WB, IHC (p), EIA Wirt: Maus Monoclonal 4A6 unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 121-271) antibodyOCRL Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 146-240) antibodyOCRL Reaktivität: Human WB, ELISA, IHC, IHC (p) Wirt: Maus Monoclonal 4A6 unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) antibodyOCRL Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 1-893) antibodyOCRL Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 1-893) antibodyOCRL Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (C-Term) antibodyOCRL Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB 1:500-1:2000, ELISA 1:10000,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C.
-
- Target
- OCRL (Oculocerebrorenal Syndrome of Lowe (OCRL))
- Andere Bezeichnung
- OCRL (OCRL Produkte)
- Synonyme
- OCRL antikoerper, wu:fi09g03 antikoerper, zgc:152864 antikoerper, locr antikoerper, nphl2 antikoerper, ocrl1 antikoerper, inpp5f antikoerper, INPP5F antikoerper, LOCR antikoerper, NPHL2 antikoerper, OCRL-1 antikoerper, OCRL1 antikoerper, 9530014D17Rik antikoerper, BB143339 antikoerper, OCRL, inositol polyphosphate-5-phosphatase antikoerper, phosphatidylinositol polyphosphate 5-phosphatase antikoerper, oculocerebrorenal syndrome of Lowe antikoerper, Ocrl antikoerper, NAEGRDRAFT_58601 antikoerper, OCRL antikoerper, ocrl antikoerper
- Molekulargewicht
- 104 kDa
- Gen-ID
- 4952
- UniProt
- Q01968
- Pathways
- Inositol Metabolic Process
-
